Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

That is not how Bio works. It's not based off share price. It's based off current drug potential and that drugs current market valuation and what the buyer expects the penetration rate.

So if P is safer than Otezla (fact). It can surpass the PASI 75 at 33% and P also comes with a 505 b 2 .... which extends exclusive rights to up to 7 years. That is what makes the buyout price. Not an artificial market price.